Dr. McCasland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2231 Hill Park Cove
Jonesboro, AR 72401Phone+1 870-333-2721Fax+1 870-333-2719
Education & Training
- Loyola University Medical CenterFellowship, Rheumatology, 2001 - 2003
- University of TennesseeResidency, Internal Medicine, 1994 - 1997
- University of Tennessee Health Science Center College of MedicineClass of 1994
Certifications & Licensure
- AR State Medical License 1998 - 2026
- IL State Medical License 2001 - 2005
- TN State Medical License 1997 - 1998
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 81 citationsEfficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial.Lars Erik Kristensen, Mauro Keiserman, Kim Papp, Leslie McCasland, Douglas White
Annals of the Rheumatic Diseases. 2022-02-01 - 16 citationsEfficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study.Lars Erik Kristensen, Mauro Keiserman, Kim Papp, Leslie McCasland, Douglas White
Rheumatology. 2023-06-01 - 1 citationsEfficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.Lars Erik Kristensen, Mauro Keiserman, Kim Papp, Leslie McCasland, Douglas White
Rheumatology and Therapy. 2024-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: